Real-world outcomes with immuno-oncology (IO) therapies: A prospective, observational cohort study in patients (pts) with advanced melanoma (OPTIMIzE).

被引：0
|
作者：
Kirkwood, John M.
Kottschade, Lisa A.
McWilliams, Robert R.
Khushalani, Nikhil I.
Jang, Sekwon
Hallmeyer, Sigrun
McDermott, David F.
Tawbi, Hussein Abdul-Hassan
Wan, Yin
Wang, Rosa
Ritchings, Corey
Rao, Sumati
Ramsey, Scott
机构：
[1] Univ Pittsburgh, Melanoma Program, UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[3] Mayo Clin, Rochester, MN USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[5] Virginia Commonwealth Univ, Inova Schar Canc Inst, Fairfax, VA USA
[6] Advocate Med Grp, Park Ridge, IL USA
[7] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[9] Bristol Myers Squibb, Princeton, NJ USA
[10] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14144
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14144
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study
    Kirkwood, John M.
    Kottschade, Lisa A.
    McWilliams, Robert R.
    Khushalani, Nikhil, I
    Jang, Sekwon
    Hallmeyer, Sigrun
    McDermott, David F.
    Tawbi, Hussein
    Che, Min
    Lee, Cho-Han
    Ritchings, Corey
    Le, Trong Kim
    Park, Boas
    Ramsey, Scott
    IMMUNOTHERAPY, 2024, 16 (01) : 29 - 42
  • [2] Real world data on the use and sequence of targeted and immuno-oncology drugs in metastatic melanoma (MM) patients (pts).
    Ortiz, Carolina
    Zamora, Esther
    Villacampa, Guillermo
    Viaplana, Cristina
    Hernando, Alberto
    Ros, Javier
    Garcia-Patos, Vicente
    Bodet, Domingo
    Fabrega, Berta Ferrer
    Recio, Juan
    Hernandez-Losa, Javier
    Dienstmann, Rodrigo
    Munoz-Couselo, Eva
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study
    Matteo Santoni
    Francesco Massari
    Zin W. Myint
    Roberto Iacovelli
    Martin Pichler
    Umberto Basso
    Jindrich Kopecky
    Jakub Kucharz
    Sebastiano Buti
    Mimma Rizzo
    Luca Galli
    Thomas Büttner
    Ugo De Giorgi
    Ravindran Kanesvaran
    Ondřej Fiala
    Enrique Grande
    Paolo Andrea Zucali
    Giuseppe Fornarini
    Maria T. Bourlon
    Sarah Scagliarini
    Javier Molina-Cerrillo
    Gaetano Aurilio
    Marc R. Matrana
    Renate Pichler
    Carlo Cattrini
    Tomas Büchler
    Emmanuel Seront
    Fabio Calabrò
    Alvaro Pinto
    Rossana Berardi
    Anca Zgura
    Giulia Mammone
    Jawaher Ansari
    Francesco Atzori
    Rita Chiari
    Aristotelis Bamias
    Orazio Caffo
    Giuseppe Procopio
    Maria Bassanelli
    Sara Merler
    Carlo Messina
    Zsófia Küronya
    Alessandra Mosca
    Dipen Bhuva
    Nuno Vau
    Lorena Incorvaia
    Sara Elena Rebuzzi
    Giandomenico Roviello
    Ignacio Ortego Zabalza
    Alessandro Rizzo
    Targeted Oncology, 2023, 18 : 559 - 570
  • [4] Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study
    Santoni, Matteo
    Massari, Francesco
    Myint, Zin W.
    Iacovelli, Roberto
    Pichler, Martin
    Basso, Umberto
    Kopecky, Jindrich
    Kucharz, Jakub
    Buti, Sebastiano
    Rizzo, Mimma
    Galli, Luca
    Buettner, Thomas
    De Giorgi, Ugo
    Kanesvaran, Ravindran
    Fiala, Ondrej
    Grande, Enrique
    Zucali, Paolo Andrea
    Fornarini, Giuseppe
    Bourlon, Maria T.
    Scagliarini, Sarah
    Molina-Cerrillo, Javier
    Aurilio, Gaetano
    Matrana, Marc R.
    Pichler, Renate
    Cattrini, Carlo
    Buechler, Tomas
    Seront, Emmanuel
    Calabro, Fabio
    Pinto, Alvaro
    Berardi, Rossana
    Zgura, Anca
    Mammone, Giulia
    Ansari, Jawaher
    Atzori, Francesco
    Chiari, Rita
    Bamias, Aristotelis
    Caffo, Orazio
    Procopio, Giuseppe
    Bassanelli, Maria
    Merler, Sara
    Messina, Carlo
    Kueronya, Zsofia
    Mosca, Alessandra
    Bhuva, Dipen
    Vau, Nuno
    Incorvaia, Lorena
    Rebuzzi, Sara Elena
    Roviello, Giandomenico
    Zabalza, Ignacio Ortego
    Rizzo, Alessandro
    TARGETED ONCOLOGY, 2023, 18 (04) : 559 - 570
  • [5] Targeted agents or immuno-oncology therapies as first-line therapy for BRAF-mutated metastatic melanoma: a real-world study
    Luke, Jason J.
    Ghate, Sameer R.
    Kish, Jonathan
    Lee, Choo Hyung
    McAllister, Lindsay
    Mehta, Sonam
    Ndife, Briana
    Feinberg, Bruce A.
    FUTURE ONCOLOGY, 2019, 15 (25) : 2933 - 2942
  • [6] Adoption of immuno-oncology in NSCLC, a real-world study in EU5.
    De Pinillos, Alejandra Martinez
    Lobera, Isabel Ricote
    Martinez, Cristina
    Anger, Caroline
    Guglielmetti, Filippo
    Bitton, Roberto Jorge
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] REAL-WORLD TREATMENT PATTERNS FOR PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) TREATED WITH IMMUNO-ONCOLOGY (IO) THERAPY
    Huang, H.
    Shenolikar, R.
    Seal, B.
    Tse, J.
    Burudpakdee, C.
    VALUE IN HEALTH, 2018, 21 : S49 - S49
  • [8] Elderly patients (pts) with advanced melanoma: Results from the prospective real-world study GEM1801
    Munoz Couselo, E.
    Ortiz Velez, C.
    Berciano-Guerrero, M-A.
    Soria, A.
    Cerezuela-Fuentes, P.
    Manzano, J. L.
    Gutierrez Sanz, L.
    Crespo, G.
    Puertolas, T.
    Garcia Castano, A.
    Aguado de la Rosa, C.
    Espinosa, E.
    Majem, M.
    Lopez Castro, R.
    Ayala de Miguel, P.
    Medina Martinez, J.
    Fernandez-Morales, L. A.
    Bellido, L.
    Martin Algarra, S.
    Marquez-Rodas, I.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S944 - S944
  • [9] Real-world study assessing physician rationale for initiating first-line (1L) immuno-oncology (IO) therapy for patients with advanced urothelial cancer (aUC)
    Ajmera, M.
    Chang, J.
    Hitchens, A.
    Kearney, M.
    Esterberg, E.
    Kim, R.
    Cappelleri, J.
    Devgan, G.
    Costa, N.
    Candrilli, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S715 - S716
  • [10] Evolving use of real-world evidence in the regulatory process: a focus on immuno-oncology treatment and outcomes
    O'Donnell, John C.
    Le, T. Kim
    Dobrin, Radu
    Higashi, Mitch
    Pereira, Ashley
    Wagner, Samuel
    Yang, Arvin
    Hukkelhoven, Mathias
    FUTURE ONCOLOGY, 2021, 17 (03) : 333 - 347
12345